Luxempart S A : Conversion of Luxempart bearer shares into dematerialized shares Appointment of LuxCSD S.A. as settlement organisation
June 25, 2023
Share
On April 24, 2023, the Extraordinary General Meeting of shareholders of Luxempart has approved the conversion of bearer shares issued by Luxempart into dematerialized shares.
The Board of Directors of Luxempart has decided to appoint LuxCSD S.A., a public limited company whose registered office is located at 42, Avenue J.F. Kennedy L - 1855 Luxembourg, registered with the Luxembourg Registre de Commerce et des Sociétés (RCS) under number B154449, as "organisme de liquidation" (settlement organisation), in accordance with the Law of April 6, 2013 relating to dematerialized securities as amended.
The dematerialization will be effective within three months after the publication of a dedicated notice to the RCS.
A FAQ explaining the main features of this dematerialization is available to shareholders and all other interested persons.
Luxempart SA published this content on 26 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 June 2023 10:25:21 UTC.
Luxempart SA is a Luxembourg-based investment company which invests in listed and private equity, as well as in private equity funds. The Company is active in Luxembourg, Belgium, France, Italy and Germany, where it manages a portfolio of listed and unlisted companies. Through Luxempart Capital Partners and Indufin Capital Partners (ICP), Luxempart also runs private equity activities. ICP is a joint-venture with the Belgian family holding Eik NV. The Company holds stakes in a number of private companies, including SES, RTL Group, Atenor, Foyer Finance, Foyer SA, SEO, PNE Wind, Pescanova, Mirato, Indufin Capital Partners - ICP Sicar, IEE, Quip, DS Care, Ekkio Capital, Thrombogenics, IP Sante domicile, Octopede Fonds private equity, among others. It also holds a majority stake in Euphaco (ABC Chemical).
LUXEMPART S.A. 
